Mortality for women with metastatic breast cancer has improved since 1990s

William Doss | | Radiology Business | Practice Management

Metastatic breast cancer is progressive and incurable, but twice as many women today are hitting the benchmark five-year survival rate as were in the early 1990s.

A study published in Cancer Epidemiology, Biomarkers and Prevention compared survival rates for women under 49 with newly diagnosed breast cancer from 1992 to 1994 with those who received the diagnosis from 2005 to 2012. While just 18 percent of the '90s cohort survived for five years, 36 percent of the '00s group survived—although the overall incidence of metastatic breast cancer increased.

This individual study didn’t delve into the specific explanations why, but lead author and statistician with the National Cancer Institute Angela B. Mariotto ascribes it to a combination of earlier screening and better treatment.

Read her New York Times interview by following the link below.

Women With Aggressive Breast Cancer Are Living Longer

William Doss

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Related Content

Radiology group cancels hospital-based business to focus on outpatient center growth
Radiology provider Akumin breaks long radio silence after emerging from bankruptcy
Doc offices more than double use of nonphysicians for interpreting medical images
Patients frequently fail to obtain follow-up imaging. Could radiologist-referrer disagreements be to blame?
3 modifiable factors that make radiology reports easier for patients to understand
Academic radiologists earn less than peers in the specialty, but the gap is closing

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.